4.5 Review

Application of CRISPR screens to investigate mammalian cell competition

Journal

BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 20, Issue 3, Pages 135-147

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elab020

Keywords

cell competition; genetic screening; CRISPR; cancer; tissue quality control

Funding

  1. Natural Sciences and Engineering Council of Canada (NSERC) [RGPIN-201906486]
  2. Canada First Research Excellence Fund (CFREF) Medicine by Design project

Ask authors/readers for more resources

Cell competition is an environment-dependent mechanism for eliminating suboptimal cells, mediated by intercellular communication and mechanical stress. While genetic drivers of cell competition have been identified in Drosophila, they remain largely elusive in mammalian models. The use of CRISPR/Cas9 screens holds promise for uncovering novel mutations that trigger cell competition and identifying essential molecular components for recognizing and eliminating less fit cells.
Cell competition is defined as the context-dependent elimination of cells that is mediated by intercellular communication, such as paracrine or contact-dependent cell signaling, and/or mechanical stresses. It is considered to be a quality control mechanism that facilitates the removal of suboptimal cells from both adult and embryonic tissues. Cell competition, however, can also be hijacked by transformed cells to acquire a 'super-competitor' status and outcompete the normal epithelium to establish a precancerous field. To date, many genetic drivers of cell competition have been identified predominately through studies in Drosophila. Especially during the last couple of years, ethylmethanesulfonate-based genetic screens have been instrumental to our understanding of the molecular regulators behind some of the most common competition mechanisms in Drosophila, namely competition due to impaired ribosomal function (or anabolism) and mechanical sensitivity. Despite recent findings in Drosophila and in mammalian models of cell competition, the drivers of mammalian cell competition remain largely elusive. Since the discovery of CRISPR/Cas9, its use in functional genomics has been indispensable to uncover novel cancer vulnerabilities. We envision that CRISPR/Cas9 screens will enable systematic, genome-scale probing of mammalian cell competition to discover novel mutations that not only trigger cell competition but also identify novel molecular components that are essential for the recognition and elimination of less fit cells. In this review, we summarize recent contributions that further our understanding of the molecular mechanisms of cell competition by genetic screening in Drosophila, and provide our perspective on how similar and novel screening strategies made possible by whole-genome CRISPR/Cas9 screening can advance our understanding of mammalian cell competition in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available